The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort. (2019)

First Author: Klatte T
Attributed to:  MICA: RIP1 kinase inhibition to reduce kidney injury funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12916-019-1419-1

PubMed Identifier: 31578141

Publication URI: http://europepmc.org/abstract/MED/31578141

Type: Journal Article/Review

Volume: 17

Parent Publication: BMC medicine

Issue: 1

ISSN: 1741-7015